中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2010年
4期
452-456
,共5页
高默杰%徐忠伟%王凤梅%陈小义%呼文亮%徐瑞成
高默傑%徐忠偉%王鳳梅%陳小義%呼文亮%徐瑞成
고묵걸%서충위%왕봉매%진소의%호문량%서서성
哇巴因%华蟾毒配基%HepG2细胞%细胞周期%细胞周期相关蛋白%细胞凋亡%钠泵
哇巴因%華蟾毒配基%HepG2細胞%細胞週期%細胞週期相關蛋白%細胞凋亡%鈉泵
왜파인%화섬독배기%HepG2세포%세포주기%세포주기상관단백%세포조망%납빙
oubain%cinbufogenin%HepG2 cell%cell cycle%cell cycle associated proteins%apoptosis%Na~+,K~+-ATPase
目的 研究钠泵抑制剂哇巴因(ouabain)和华蟾毒配基(cinobufogenin)对人肝癌HepG2细胞增殖的抑制作用及细胞周期的改变,初步分析其机制.方法 以人肝癌细胞HepG2为靶细胞,MTT比色法检测哇巴因和华蟾毒配基对HepG2细胞增殖的影响;Hoechst 33342荧光染色检测细胞形态学变化;流式细胞术检测细胞周期;实时定量PCR和Western blot检测CyclinA1、CDK2、PCNA和p21~(CIP1)表达的变化.结果 哇巴因和华蟾毒配基可明显抑制HepG2细胞增殖,抑制作用呈时间-浓度依赖性.荧光染色显示药物处理24 h后,细胞呈现典型的凋亡形态特征;细胞周期分析显示,实验组S期细胞比例升高,实时定量PCR和Western blot结果显示:哇巴因和华蟾毒配基可下调CyclinA1、CDK2和PCNA的表达(P<0.05),上调p21~(CIP1)的表达(P<0.05).结论 钠泵抑制剂可抑制肝癌HepG2细胞的增殖,引起细胞周期S期阻滞,诱导细胞凋亡,这与其调节细胞周期相关蛋白的生成关系密切.
目的 研究鈉泵抑製劑哇巴因(ouabain)和華蟾毒配基(cinobufogenin)對人肝癌HepG2細胞增殖的抑製作用及細胞週期的改變,初步分析其機製.方法 以人肝癌細胞HepG2為靶細胞,MTT比色法檢測哇巴因和華蟾毒配基對HepG2細胞增殖的影響;Hoechst 33342熒光染色檢測細胞形態學變化;流式細胞術檢測細胞週期;實時定量PCR和Western blot檢測CyclinA1、CDK2、PCNA和p21~(CIP1)錶達的變化.結果 哇巴因和華蟾毒配基可明顯抑製HepG2細胞增殖,抑製作用呈時間-濃度依賴性.熒光染色顯示藥物處理24 h後,細胞呈現典型的凋亡形態特徵;細胞週期分析顯示,實驗組S期細胞比例升高,實時定量PCR和Western blot結果顯示:哇巴因和華蟾毒配基可下調CyclinA1、CDK2和PCNA的錶達(P<0.05),上調p21~(CIP1)的錶達(P<0.05).結論 鈉泵抑製劑可抑製肝癌HepG2細胞的增殖,引起細胞週期S期阻滯,誘導細胞凋亡,這與其調節細胞週期相關蛋白的生成關繫密切.
목적 연구납빙억제제왜파인(ouabain)화화섬독배기(cinobufogenin)대인간암HepG2세포증식적억제작용급세포주기적개변,초보분석기궤제.방법 이인간암세포HepG2위파세포,MTT비색법검측왜파인화화섬독배기대HepG2세포증식적영향;Hoechst 33342형광염색검측세포형태학변화;류식세포술검측세포주기;실시정량PCR화Western blot검측CyclinA1、CDK2、PCNA화p21~(CIP1)표체적변화.결과 왜파인화화섬독배기가명현억제HepG2세포증식,억제작용정시간-농도의뢰성.형광염색현시약물처리24 h후,세포정현전형적조망형태특정;세포주기분석현시,실험조S기세포비례승고,실시정량PCR화Western blot결과현시:왜파인화화섬독배기가하조CyclinA1、CDK2화PCNA적표체(P<0.05),상조p21~(CIP1)적표체(P<0.05).결론 납빙억제제가억제간암HepG2세포적증식,인기세포주기S기조체,유도세포조망,저여기조절세포주기상관단백적생성관계밀절.
Aim To investigate the effect of ouabain and cinobufogenin on cell proliferation,apoptosis and cell cycle on HepG2,and explore their molecular mechanism.Methods The anti-proliferative effect on HepG2 cells was determined by MTT assay.The HepG2 cells were stained with Hoechst 33342,and its morphological changes were observed under fluorescence microscope;The cell cycle was measured by flow cytometry.The Cyclin A1,CDK 2,PCNA and p21~(CIP1) expression levels of HepG2 cells treated with ouabain and cinobufogenin were dectected in mRNA and protein by Real time PCR and Western blot.Results Ouabain and cinobufogenin could inhibit cell proliferation on HepG2 cells,and the inhibitory effects were in time and dose dependent manners.The HepG2 cells treated with ouabain and cinobufogenin showed the typical morphological features of apoptosis.Cell cycle analysis showed that the S phase of HepG2 cells treated with ouabain and cinobufogenin increased significantly compared with the control group.Real-time quantitative PCR and Western blot results showed that ouabain and cinobufogenin could down-regulate Cyclin A1,CDK 2,and PCNA expressions(P<0.05)and up-regulate p21~(CIP1) expression(P<0.05).Conclusion Nα~+,K~+-ATPase inhibitor has the anti-proliferative effect on HepG2 cells and induce apoptosis and S phase arrest.These effects might be related with proteins associated with cell cycle closely.